Pfiz­er tags ear­ly re­search pro­grams for 'ex­ter­nal­iza­tion' as it nar­rows fo­cus in rare dis­ease, can­cer

Pfiz­er is look­ing to di­vest a sig­nif­i­cant por­tion of its ear­ly-stage re­search pro­grams in rare dis­ease and on­col­o­gy as it re­thinks the way it ap­proach­es …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER